302 related articles for article (PubMed ID: 21380595)
1. Effects of a germ-free environment on gut immune regulation and diabetes progression in non-obese diabetic (NOD) mice.
Alam C; Bittoun E; Bhagwat D; Valkonen S; Saari A; Jaakkola U; Eerola E; Huovinen P; Hänninen A
Diabetologia; 2011 Jun; 54(6):1398-406. PubMed ID: 21380595
[TBL] [Abstract][Full Text] [Related]
2. Antidiabetic and Immunoregulatory Activities of Extract of
Lin CH; Kuo YH; Shih CC
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373070
[TBL] [Abstract][Full Text] [Related]
3. β-cell-specific IL-2 therapy increases islet Foxp3+Treg and suppresses type 1 diabetes in NOD mice.
Johnson MC; Garland AL; Nicolson SC; Li C; Samulski RJ; Wang B; Tisch R
Diabetes; 2013 Nov; 62(11):3775-84. PubMed ID: 23884888
[TBL] [Abstract][Full Text] [Related]
4. KLRG1 expression identifies short-lived Foxp3
Kornete M; Mason E; Istomine R; Piccirillo CA
Autoimmunity; 2017 Sep; 50(6):354-362. PubMed ID: 28850267
[TBL] [Abstract][Full Text] [Related]
5. A Novel Liposome Formulation Carrying Both an Insulin Peptide and a Ligand for Invariant Natural Killer T Cells Induces Accumulation of Regulatory T Cells to Islets in Nonobese Diabetic Mice.
Akimoto H; Fukuda-Kawaguchi E; Duramad O; Ishii Y; Tanabe K
J Diabetes Res; 2019; 2019():9430473. PubMed ID: 31781669
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-12 converts Foxp3+ regulatory T cells to interferon-γ-producing Foxp3+ T cells that inhibit colitis.
Feng T; Cao AT; Weaver CT; Elson CO; Cong Y
Gastroenterology; 2011 Jun; 140(7):2031-43. PubMed ID: 21419767
[TBL] [Abstract][Full Text] [Related]
7. Thymically-derived Foxp3+ regulatory T cells are the primary regulators of type 1 diabetes in the non-obese diabetic mouse model.
Holohan DR; Van Gool F; Bluestone JA
PLoS One; 2019; 14(10):e0217728. PubMed ID: 31647813
[TBL] [Abstract][Full Text] [Related]
8. Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T cells.
Mellanby RJ; Thomas D; Phillips JM; Cooke A
Immunology; 2007 May; 121(1):15-28. PubMed ID: 17428252
[TBL] [Abstract][Full Text] [Related]
9. IL-33 Prevents MLD-STZ Induction of Diabetes and Attenuate Insulitis in Prediabetic NOD Mice.
Pavlovic S; Petrovic I; Jovicic N; Ljujic B; Miletic Kovacevic M; Arsenijevic N; Lukic ML
Front Immunol; 2018; 9():2646. PubMed ID: 30498495
[TBL] [Abstract][Full Text] [Related]
10. Combined insulin B:9-23 self-peptide and polyinosinic-polycytidylic acid accelerate insulitis but inhibit development of diabetes by increasing the proportion of CD4+Foxp3+ regulatory T cells in the islets in non-obese diabetic mice.
Fukushima K; Abiru N; Nagayama Y; Kobayashi M; Satoh T; Nakahara M; Kawasaki E; Yamasaki H; Ueha S; Matsushima K; Liu E; Eguchi K
Biochem Biophys Res Commun; 2008 Mar; 367(4):719-24. PubMed ID: 18194666
[TBL] [Abstract][Full Text] [Related]
11. Gut microbial markers are associated with diabetes onset, regulatory imbalance, and IFN-γ level in NOD mice.
Krych Ł; Nielsen DS; Hansen AK; Hansen CH
Gut Microbes; 2015; 6(2):101-9. PubMed ID: 25648687
[TBL] [Abstract][Full Text] [Related]
12. Activation of the Aryl Hydrocarbon Receptor by 10-Cl-BBQ Prevents Insulitis and Effector T Cell Development Independently of Foxp3+ Regulatory T Cells in Nonobese Diabetic Mice.
Ehrlich AK; Pennington JM; Wang X; Rohlman D; Punj S; Löhr CV; Newman MT; Kolluri SK; Kerkvliet NI
J Immunol; 2016 Jan; 196(1):264-73. PubMed ID: 26573835
[TBL] [Abstract][Full Text] [Related]
13. Acceleration of diabetes development in CXC chemokine receptor 3 (CXCR3)-deficient NOD mice.
Yamada Y; Okubo Y; Shimada A; Oikawa Y; Yamada S; Narumi S; Matsushima K; Itoh H
Diabetologia; 2012 Aug; 55(8):2238-45. PubMed ID: 22487925
[TBL] [Abstract][Full Text] [Related]
14. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis.
Lee YK; Menezes JS; Umesaki Y; Mazmanian SK
Proc Natl Acad Sci U S A; 2011 Mar; 108 Suppl 1(Suppl 1):4615-22. PubMed ID: 20660719
[TBL] [Abstract][Full Text] [Related]
15. Activated protein C inhibits pancreatic islet inflammation, stimulates T regulatory cells, and prevents diabetes in non-obese diabetic (NOD) mice.
Xue M; Dervish S; Harrison LC; Fulcher G; Jackson CJ
J Biol Chem; 2012 May; 287(20):16356-64. PubMed ID: 22447930
[TBL] [Abstract][Full Text] [Related]
16. Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice.
Tarbell KV; Petit L; Zuo X; Toy P; Luo X; Mqadmi A; Yang H; Suthanthiran M; Mojsov S; Steinman RM
J Exp Med; 2007 Jan; 204(1):191-201. PubMed ID: 17210729
[TBL] [Abstract][Full Text] [Related]
17.
Hänninen A; Toivonen R; Pöysti S; Belzer C; Plovier H; Ouwerkerk JP; Emani R; Cani PD; De Vos WM
Gut; 2018 Aug; 67(8):1445-1453. PubMed ID: 29269438
[TBL] [Abstract][Full Text] [Related]
18. Disruption of the homeostatic balance between autoaggressive (CD4+CD40+) and regulatory (CD4+CD25+FoxP3+) T cells promotes diabetes.
Waid DM; Vaitaitis GM; Pennock ND; Wagner DH
J Leukoc Biol; 2008 Aug; 84(2):431-9. PubMed ID: 18469093
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells.
Madec AM; Mallone R; Afonso G; Abou Mrad E; Mesnier A; Eljaafari A; Thivolet C
Diabetologia; 2009 Jul; 52(7):1391-9. PubMed ID: 19421731
[TBL] [Abstract][Full Text] [Related]
20. Consumption of acidic water alters the gut microbiome and decreases the risk of diabetes in NOD mice.
Wolf KJ; Daft JG; Tanner SM; Hartmann R; Khafipour E; Lorenz RG
J Histochem Cytochem; 2014 Apr; 62(4):237-50. PubMed ID: 24453191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
